icon

Periodic/Annual financial statements

فارسی
Company:
گروه دارويي سبحان
Listed capital:
1,670,000
Symbol:
دسبحا
Unauthorized capital:
0
ISIC Code:
432321
Periodic/Annual financial statements  6 monthly End to 1396/06/31 (Unaudited)
Year end to date:
1396/12/29
Publisher status:
پذيرفته شده در بورس تهران
information The displayed data is matche to signed data.

All amounts are in Million rials

Export To Excel
این اطلاعیه اصلاحیه اطلاعیه شماره ( 384783 ) می باشد. نسخه قبلی اطلاعیه را می توانید در اینجا مشاهده نمایید

DescriptionEnd of real to
1396/06/31
End of past financial year
1395/12/30
Percent of
changes
DescriptionEnd of real to
1396/06/31
End of past financial year
1395/12/30
Percent of
changes
Current assets Liabilities
Current assets Current liabilities
Cash 19,601 7,506 161 Commercial payments 0 0 --
Current investments 0 0 -- Non-commercial payments 6,555 7,233 (9)
Trade receivables 282,689 1,304,117 (78) Current tax liabilities 0 0 --
Non-trade receivables 90,118 82,604 9 Dividend payables 610,184 53,238 1,046
Current prepayments 355 397 (11) Current financial liabilities at amortised cost 0 0 --
Non-current assets or disposal groups classified as held for sale or as held for distribution to owners 0 0 -- Provisions 0 0 --
Total Current assets 392,763 1,394,624 (72) Deferred income classified as current 0 0 --
Non-current assets Liabilities included in disposal groups classified as held for sale 0 0 --
Non-current receivables 136,564 173,281 (21) Total Current liabilities 616,739 60,471 920
Non-current investments 2,101,501 1,786,564 18 Non-current liabilities
Investment property 0 0 -- Non-current payables 0 0 --
Intangible assets other than goodwill 6 6 0 Deferred income classified as non-current 0 0 --
Property, plant and equipment 1,577 1,193 32 Non-Current financial liabilities at amortised cost 0 0 --
Other assets 0 0 -- Provisions for employee benefits 1,487 1,179 26
Total Non-current assets 2,239,648 1,961,044 14 Total Non-current liabilities 1,487 1,179 26
Total Liabilities 618,226 61,650 903
Equity
Issued capital 1,375,000 1,004,000 37
In-process capital increase 0 371,000 --
Share premium 0 0 --
Treasury shares 0 0 --
Statutory reserve 100,400 100,400 0
Other reserves 0 0 --
Revaluation surplus of non-current assets held for sale 0 0 --
Revaluation surplus 0 0 --
Exchange differences on translation‌ 0 0 --
Exchange reserve for governmental corporations' assets and liabilities 0 0 --
Retained earnings 538,785 1,818,618 (70)
Total Equity 2,014,185 3,294,018 (39)
Total Assets 2,632,411 3,355,668 (22) Total Equity and liabilities 2,632,411 3,355,668 (22)